Progress in targeted therapy for breast cancer.

Chronic Dis Transl Med · 2018 · PMC6160667 · PMID 30276363

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

An interim analysis of the OS showed a strong trend in favor of the docetaxel plus trastuzumab and pertuzumab regimen, although it was not significant.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.